carbon tetrachloride has been researched along with plerixafor in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cameron, AM; Knabel, MK; Locke, JE; Lonze, BE; Mark, AL; Melville Williams, GM; Montgomery, RA; Sun, Z; Warren, DS | 1 |
Anagnostopoulos, A; Athanasiou, E; Gounari, E; Siotou, E; Tsolaki, E; Yannaki, E; Yiangou, M; Zogas, N | 1 |
Chan, KM; Chen, Y; Chern, GG; Chiang, T; Hsu, FF; Liu, CH; Liu, JY; Liu, YC; Wu, YH | 1 |
4 other study(ies) available for carbon tetrachloride and plerixafor
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Stem cell mobilization is life saving in an animal model of acute liver failure.
Topics: Animals; Antigens, CD34; Benzylamines; Carbon Tetrachloride; Cyclams; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Immunohistochemistry; Liver; Liver Failure, Acute; Mice; Rats; Rats, Inbred Lew; Transaminases | 2010 |
Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury.
Topics: Animals; Benzylamines; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Chronic; Cyclams; Fibrosis; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Immunohistochemistry; Liver; Liver Regeneration; Mice; Time Factors | 2014 |
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cyclams; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neovascularization, Pathologic; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor A | 2016 |